Amplia Therapeutics Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amplia Therapeutics Ltd with three other
companies in this sector in Australia:
Race Oncology Ltd
(2019
sales of 17,355.00 Australian Dollars [US$11,870.65 ]
),
Dimerix Ltd
(18,108.00 Australian Dollars [US$12,385.69 ]
), and
Antisense Therapeutics Limited
(66,168.00 Australian Dollars [US$45,258.25 ]
).
Sales Analysis.
Sales fell dramatically in 2019:
Amplia Therapeutics Ltd reported sales of A$50,474.00 (US$34.52 thousand)
for the
fiscal
year ending
March of 2019.
This
represents
a
sharp
decrease of 92.1%
versus 2018, when the company's sales were A$642,837.00 .